Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2012, Article ID 523840, 8 pages
http://dx.doi.org/10.1100/2012/523840
Research Article

Assessment of Control Tissue for Gene and Protein Expression Studies: A Comparison of Three Alternative Lung Sources

1Critical Care Research Group, University of Queensland, Prince Charles Hospital, Brisbane, Australia
2Department of Medicine, University of Queensland, Prince Charles Hospital, Brisbane, Australia

Received 14 October 2011; Accepted 24 November 2011

Academic Editors: K. Gillespie and K. Kiura

Copyright © 2012 Margaret R. Passmore et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Andersson-Sjöland, J. S. Erjefält, L. Bjermer, L. Eriksson, and G. Westergren-Thorsson, “Fibrocytes are associated with vascular and parenchymal remodelling in patients with obliterative bronchiolitis,” Respiratory Research, vol. 10, p. 103, 2009. View at Google Scholar · View at Scopus
  2. S. Baraldo, G. Turato, C. Badin et al., “Neutrophilic infiltration within the airway smooth muscle in patients with COPD,” Thorax, vol. 59, no. 4, pp. 308–312, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. J. M. Charpin, M. Stern, G. Lebrun, P. Aubin, D. Grenet, and D. Israël-Biet, “Increased endothelin-1 associated with bacterial infection in lung transplant recipients,” Transplantation, vol. 71, no. 12, pp. 1840–1847, 2001. View at Google Scholar · View at Scopus
  4. K. Koli, M. Myllärniemi, K. Vuorinen et al., “Bone morphogenetic protein-4 inhibitor Gremlin is overexpressed in idiopathic pulmonary fibrosis,” American Journal of Pathology, vol. 169, no. 1, pp. 61–71, 2006. View at Publisher · View at Google Scholar
  5. J. McLaren, A. Prentice, D. S. Charnock-Jones et al., “Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids,” Journal of Clinical Investigation, vol. 98, no. 2, pp. 482–489, 1996. View at Google Scholar · View at Scopus
  6. Y. Sugishita, T. Shimizu, A. Yao et al., “Lipopolysaccharide augments expression and secretion of vascular endothelial growth factor in rat ventricular myocytes,” Biochemical and Biophysical Research Communications, vol. 268, no. 2, pp. 657–662, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Lahm, P. R. Crisostomo, T. A. Markel, M. Wang, K. D. Lillemoe, and D. R. Meldrum, “The critical role of vascular endothelial growth factor in pulmonary vascular remodeling after lung injury,” Shock, vol. 28, no. 1, pp. 4–14, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. R. J. Kaner, J. V. Ladetto, R. Singh, N. Fukuda, M. A. Matthay, and R. G. Crystal, “Lung overexpression of the vascular endothelial growth factor gene induces pulmonary edema,” American Journal of Respiratory Cell and Molecular Biology, vol. 22, no. 6, pp. 657–664, 2000. View at Google Scholar · View at Scopus
  9. P. N. Tsao, Y. N. Su, H. Li et al., “Overexpression of placenta growth factor contributes to the pathogenesis of pulmonary emphysema,” American Journal of Respiratory and Critical Care Medicine, vol. 169, no. 4, pp. 505–511, 2004. View at Google Scholar · View at Scopus
  10. K. Krenn, W. Klepetko, S. Taghavi, G. Lang, B. Schneider, and S. Aharinejad, “Recipient vascular endothelial growth factor serum levels predict primary lung graft dysfunction,” American Journal of Transplantation, vol. 7, no. 3, pp. 700–706, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. C. C. Yang, K. C. Chu, and W. M. Yeh, “The expression of vascular endothelial growth factor in transitional cell carcinoma of urinary bladder is correlated with cancer progression,” Urologic Oncology, vol. 22, no. 1, pp. 1–6, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Granata, A. Frattini, S. Loffredo et al., “Production of vascular endothelial growth factors from human lung macrophages induced by group IIA and group X secreted phospholipases A2,” Journal of Immunology, vol. 184, no. 9, pp. 5232–5241, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. W. Yang, H. Ahn, M. Hinrichs, R. J. Torry, and D. S. Torry, “Evidence of a novel isoform of placenta growth factor (P1GF-4) expressed in human trophoblast and endothelial cells,” Journal of Reproductive Immunology, vol. 60, no. 1, pp. 53–60, 2003. View at Publisher · View at Google Scholar
  14. C. N. Chen, F. J. Hsieh, Y. M. Cheng et al., “The significance of placenta growth factor in angiogenesis and clinical outcome of human gastric cancer,” Cancer Letters, vol. 213, no. 1, pp. 73–82, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Luttun, M. Tjwa, L. Moons et al., “Revascularization of ischemic tissues by PLGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1,” Nature Medicine, vol. 8, no. 8, pp. 831–840, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. D. R. Thickett, L. Armstrong, S. J. Christie, and A. B. Millar, “Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome,” American Journal of Respiratory and Critical Care Medicine, vol. 164, no. 9, pp. 1601–1605, 2001. View at Google Scholar · View at Scopus
  17. T. Shimoyama, N. Tabuchi, J. Chung, T. Koyama, and M. Sunamori, “Matrix metalloproteinase inhibitor (ONO-4817) attenuates ischemia-reperfusion injury in rat lung,” Medical Science Monitor, vol. 12, no. 2, pp. BR51–BR56, 2006. View at Google Scholar · View at Scopus
  18. A. K. Chow, J. Cena, and R. Schulz, “Acute actions and novel targets of matrix metalloproteinases in the heart and vasculature,” British Journal of Pharmacology, vol. 152, no. 2, pp. 189–205, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Rydlova, L. Holubec, M. Ludvikova et al., “Biological activity and clinical implications of the matrix metalloproteinases,” Anticancer Research, vol. 28, no. 2B, pp. 1389–1397, 2008. View at Google Scholar · View at Scopus
  20. S. E. Gill and W. C. Parks, “Metalloproteinases and their inhibitors: regulators of wound healing,” International Journal of Biochemistry and Cell Biology, vol. 40, no. 6-7, pp. 1334–1347, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Page-McCaw, A. J. Ewald, and Z. Werb, “Matrix metalloproteinases and the regulation of tissue remodelling,” Nature Reviews Molecular Cell Biology, vol. 8, no. 3, pp. 221–233, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. A. R. Medford, S. K. Douglas, S. I. Godinho et al., “Vascular Endothelial Growth Factor (VEGF) isoform expression and activity in human and murine lung injury,” Respiratory Research, vol. 10, p. 27, 2009. View at Google Scholar · View at Scopus
  23. M. Gry, R. Rimini, S. Strömberg et al., “Correlations between RNA and protein expression profiles in 23 human cell lines,” BMC Genomics, vol. 10, article 365, 2009. View at Publisher · View at Google Scholar
  24. G. Kerst, N. Bergold, F. Gieseke et al., “WT1 protein expression in childhood acute leukemia,” American Journal of Hematology, vol. 83, no. 5, pp. 382–386, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Kudo, I. Ajioka, Y. Hirata, and K. Nakajima, “Expression profiles of EphA3 at both the RNA and protein level in the developing mammalian forebrain,” Journal of Comparative Neurology, vol. 487, no. 3, pp. 255–269, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. A. W. Tank, L. Xu, X. Chen, P. Radcliffe, and C. R. Sterling, “Post-transcriptional regulation of tyrosine hydroxylase expression in adrenal medulla and brain,” Annals of the New York Academy of Sciences, vol. 1148, pp. 238–248, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Takekoshi, K. Isobe, T. Yashiro et al., “Expression of vascular endothelial growth factor (VEGF) and its cognate receptors in human pheochromocytomas,” Life Sciences, vol. 74, no. 7, pp. 863–871, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Matsumoto and L. Claesson-Welsh, “VEGF receptor signal transduction,” Sci STKE, vol. 2001, no. 112, p. RE21, 2001. View at Google Scholar · View at Scopus
  29. C. Fischer, B. Jonckx, M. Mazzone et al., “Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels,” Cell, vol. 131, no. 3, pp. 463–475, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. L. Zhang, J. Chen, Y. Ke, R. E. Mansel, and W. G. Jiang, “Expression of placenta growth factor (PIGF) in non-small cell lung cancer (NSCLC) and the clinical and prognostic significance,” World Journal of Surgical Oncology, vol. 3, article no. 68, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. C. M. Rudin, E. Avila-Tang, C. C. Harris et al., “Lung cancer in never smokers: molecular profiles and therapeutic implications,” Clinical Cancer Research, vol. 15, no. 18, pp. 5646–5661, 2009. View at Publisher · View at Google Scholar · View at Scopus